Modulation of α2C adrenergic receptor temperature-sensitive trafficking by HSP90

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 2, 2011, Pages 346-357

  Filipeanu, Catalin M ^a   de Vries, René ^b   Danser, A H Jan ^b   Kapusta, Daniel R ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

2C AR; Heat shock proteins; HSP90; Intracellular traffic; Low temperature; Molecular chaperones; Raynaud Phenomenon

Indexed keywords

ALPHA 2C ADRENERGIC RECEPTOR; ALVESPIMYCIN; ANTINEOPLASTIC ANTIBIOTIC; BETA ACTIN; BIOCHEMICAL MARKER; CELL SURFACE RECEPTOR; DIMETHYL SULFOXIDE; GLYCEROL; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; MACBECIN; RADICICOL; RADIOLIGAND; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE TRANSPORT; ENDOPLASMIC RETICULUM; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERNALIZATION; INTRACELLULAR TRANSPORT; LIGAND BINDING; LOW TEMPERATURE; LYSOSOME; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; RAYNAUD PHENOMENON; RECEPTOR UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIES; BENZOQUINONES; CELL MEMBRANE; CELLS, CULTURED; ENZYME INHIBITORS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; KIDNEY; LACTAMS, MACROCYCLIC; MACROLIDES; MALE; MUSCLE, SMOOTH, VASCULAR; PROTEIN TRANSPORT; PROTEIN-TYROSINE KINASES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; RNA, SMALL INTERFERING; SUBCELLULAR FRACTIONS; TEMPERATURE;

RATTUS;

EID: 78650943372     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.11.020     Document Type: Article

References (55)

1. Small K.M., McGraw D.W., Liggett S.B. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu. Rev. Pharmacol. Toxicol. 2003, 43:381-411.
2. Saunders Test C. Localization and trafficking of alpha2-adrenergic receptor subtypes in cells and tissues. Pharmacol. Ther. 1999, 84:193-205.
3. MacDonald E., Kobilka B.K., Scheinin M. Gene targeting-homing in on alpha 2-adrenoceptor subtype function. Trends Pharmacol. Sci. 1997, 18:211-219.
4. Brede M., Philipp M., Knaus A., Muthig V., Hein L. Alpha2-adrenergic receptor subtypes - novel functions uncovered in gene-targeted mouse models. Biol. Cell 2004, 96:343-348.
5. Knaus A.E., Muthig V., Schickinger S., Moura E., Beetz N., Gilsbach R., Hein L. Alpha2-adrenoceptor subtypes - unexpected functions for receptors and ligands derived from gene-targeted mouse models. Neurochem. Int. 2007, 51:277-281.
6. Eason M.G., Liggett S.B. Identification of a Gs coupling domain in the amino terminus of the third intracellular loop of the alpha 2A-adrenergic receptor. Evidence for distinct structural determinants that confer Gs versus Gi coupling. J. Biol. Chem. 1995, 270:24753-24760.
7. Wade S.M., Lim W.K., Lan K.L., Chung D.A., Nanamori M., Neubig R.R. G(i) activator region of alpha(2A)-adrenergic receptors: distinct basic residues mediate G(i) versus G(s) activation. Mol. Pharmacol. 1999, 56:1005-1013.
8. Daunt D.A., Hurt C., Hein L., Kallio J., Feng F., Kobilka B.K. Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol. Pharmacol. 1997, 51:711-720.
9. Hurt C.M., Feng F.Y., Kobilka B. Cell-type specific targeting of the alpha 2c-adrenoceptor. Evidence for the organization of receptor microdomains during neuronal differentiation of PC12 cells. J. Biol. Chem. 2000, 275:35424-35431.
10. Wigley F.M. Raynaud's Phenomenon. N. Engl. J. Med. 2002, 347:1001-1008.
11. Flavahan N.A. Regulation of vascular reactivity in scleroderma: new insights into Raynaud's phenomenon. Rheum. Dis. Clin. North Am. 2008, 34:81-87.
12. Flavahan N.A., Lindblad L.E., Verbeuren T.J., Shepherd J.T., Vanhoutte P.M. Cooling and alpha 1- and alpha 2-adrenergic responses in cutaneous veins: role of receptor reserve. Am. J. Physiol. 1985, 249:H950-H955.
13. Freedman R.R., Baer R.P., Mayes M.D. Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease. Circulation 1995, 92:1448-1451.
14. Chotani M.A., Flavahan S., Mitra S., Daunt D., Flavahan N.A. Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H1075-H1083.
15. Bailey S.R., Eid A.H., Mitra S., Flavahan S., Flavahan N.A. Rho kinase mediates cold-induced constriction of cutaneous arteries: role of alpha2C-adrenoceptor translocation. Circ. Res. 2004, 94:1367-1374.
16. Duvernay M.T., Filipeanu C.M., Wu G. The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell. Signal. 2005, 17:1457-1465.
17. Dong C., Filipeanu C.M., Duvernay M.T., Wu G. Regulation of G protein-coupled receptor export trafficking. Biochim. Biophys. Acta 2007, 1768:853-870.
18. Conn P.M., Janovick J.A., Brothers S.P., Knollman P.E. 'Effective inefficiency': cellular control of protein trafficking as a mechanism of post-translational regulation. J. Endocrinol. 2006, 190:13-16.
19. Ritter S.L., Hall R.A. Fine-tuning of GPCR activity by receptor-interacting proteins. Nat. Rev. Mol. Cell Biol. 2009, 10:819-830.
20. Petaja-Repo U.E., Hogue M., Laperriere A., Walker P., Bouvier M. Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor. J. Biol. Chem. 2000, 275:13727-13736.
21. Wang X., Venable J., LaPointe P., Hutt D.M., Koulov A.V., Coppinger J., Gurkan C., Kellner W., Matteson J., Plutner H., Riordan J.R., Kelly J.W., Yates J.R., Balch W.E. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 2006, 127:803-815.
22. Ramos R.R., Swanson A.J., Bass J. Calreticulin and Hsp90 stabilize the human insulin receptor and promote its mobility in the endoplasmic reticulum. Proc. Natl Acad. Sci. USA 2007, 104:10470-10475.
23. Luo S., Zhang B., Dong X.P., Tao Y., Ting A., Zhou Test Z. HSP90 beta regulates rapsyn turnover and subsequent AChR cluster formation and maintenance. Neuron 2008, 60:97-110.
24. Robben J.H., Deen P.M. Pharmacological chaperones in nephrogenic diabetes insipidus: possibilities for clinical application. BioDrugs 2007, 21:157-166.
25. Kim I., Xu W., Reed J.C. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 2008, 7:1013-1030.
26. Hegedus T., Aleksandrov A., Cui L., Gentzsch M., Chang X.B., Riordan J.R. F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive. Biochim. Biophys. Acta 2006, 1758:565-572.
27. Wang L., Dennis A.T., Trieu P., Charron F., Ethier N., Hebert T.E., Wan X., Ficker E. Intracellular potassium stabilizes human ether-à-go-go-related gene channels for export from endoplasmic reticulum. Mol. Pharmacol. 2009, 75:927-937.
28. Al-Fageeh M.B., Smales C.M. Control and regulation of the cellular responses to cold shock: the responses in yeast and mammalian systems. Biochem. J. 2006, 397:247-259.
29. Zhou F., Filipeanu C.M., Duvernay M.T., Wu G. Cell-surface targeting of alpha2-adrenergic receptors - inhibition by a transport deficient mutant through dimerization. Cell. Signal. 2006, 18:318-327.
30. Filipeanu C.M., Zhou F., Claycomb W.C., Wu G. Regulation of the cell surface expression and function of angiotensin II type 1 receptor by Rab1-mediated endoplasmic reticulum-to-Golgi transport in cardiac myocytes. J. Biol. Chem. 2004, 279:41077-41084.
31. Filipeanu C.M., Zhou F., Fugetta E.K. G Wu, Differential regulation of the cell-surface targeting and function of beta- and alpha1-adrenergic receptors by Rab1 GTPase in cardiac myocytes. Mol. Pharmacol. 2006, 69:1571-1578.
32. Filipeanu C.M., Zhou F., Lam M.L., Kerut K.E., Claycomb W.C., Wu G. Enhancement of the recycling and activation of beta-adrenergic receptor by Rab4 GTPase in cardiac myocytes. J. Biol. Chem. 2006, 281:11097-11103.
33. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 1977, 41:19-26.
34. Small K.M., Forbes S.L., Rahman F.F., Bridges K.M., Liggett S.B. A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors. J. Biol. Chem. 2000, 275:23059-23064.
35. Kurnik D., Friedman E.A., Muszkat M., Sofowora G.G., Xie H.G., Dupont W.D., Wood A.J., Stein C.M. Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses. Pharmacogenet. Genomics 2008, 18:743-750.
36. Picard D. Heat-shock protein 90, a chaperone for folding and regulation. Cell. Mol. Life Sci. 2002, 59:1640-1648.
37. Taherian A., Krone P.H., Ovsenek N. A comparison of Hsp90alpha and Hsp90beta interactions with cochaperones and substrates. Biochem. Cell Biol. 2008, 86:37-45.
38. Wandinger S.K., Richter K., Buchner J. The Hsp90 chaperone machinery. J. Biol. Chem. 2008, 283:18473-18477.
39. Jeyaraj S.C., Chotani M.A., Mitra S., Gregg H.E., Flavahan N.A., Morrison K.J. Cooling evokes redistribution of alpha2C-adrenoceptors from Golgi to plasma membrane in transfected human embryonic kidney 293 cells. Mol. Pharmacol. 2001, 60:1195-1200.
40. Angelotti T., Daunt D., Shcherbakova O.G., Kobilka B., Hurt C.M. Regulation of G-protein coupled receptor traffic by an evolutionary conserved hydrophobic signal. Traffic 2010, 11:560-578.
41. He F., Qiao Z.H., Cai J., Pierce W., He D.C., Song Z.H. Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor. Mol. Pharmacol. 2007, 72:1289-1300.
42. Xu W., Mimnaugh E., Rosser M.F., Nicchitta C., Marcu M., Yarden Y., Neckers L. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J. Biol. Chem. 2001, 276:3702-3708.
43. Argon Y., Simen B.B. GRP94, an ER chaperone with protein and peptide binding properties. Semin. Cell Dev. Biol. 1999, 10:495-505.
44. Filipeanu C.M., Henning R.H., Nelemans S.A., de Zeeuw D. Intracellular angiotensin II: from myth to reality?. J. Renin Angiotensin Aldosterone Syst. 2001, 2:219-226.
45. O'Malley K.L., Jong Y.J., Gonchar Y., Burkhalter A., Romano C. Activation of metabotropic glutamate receptor mGlu5 on nuclear membranes mediates intranuclear Ca2+ changes in heterologous cell types and neurons. J. Biol. Chem. 2003, 278:28210-28219.
46. Rozenfeld R., Devi L.A. Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. FASEB J. 2008, 22:2311-2322.
47. Dupré D.J., Robitaille M., Ethier N., Villeneuve L.R., Mamarbachi A.M., Hébert T.E. Seven transmembrane receptor core signaling complexes are assembled prior to plasma membrane trafficking. J. Biol. Chem. 2006, 281:34561-34573.
48. Quraishi H., Brown I.R. Expression of heat shock protein 90 (hsp90) in neural and nonneural tissues of the control and hyperthermic rabbit. Exp. Cell Res. 1995, 219:358-363.
49. Yetik-Anacak G., Xia T., Dimitropoulou C., Venema R.C., Catravas J.D. Effects of hsp90 binding inhibitors on sGC-mediated vascular relaxation. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H260-H268.
50. Han G., Ma H., Chintala R., Fulton D.J., Barman S.A., White R.E. Essential role of the 90-kilodalton heat shock protein in mediating nongenomic estrogen signaling in coronary artery smooth muscle. J. Pharmacol. Exp. Ther. 2009, 329:850-855.
51. Koga F., Kihara K., Necker L. Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90. Anticancer Res. 2009, 29:797-807.
52. Taldone T., Gozman A., Maharaj R., Chiosis G. Targeting Hsp90: small-molecule inhibitors and their clinical development. Curr. Opin. Pharmacol. 2008, 8:370-374.
53. Eid A.H., Maiti K., Mitra S., Chotani M.A., Flavahan S., Bailey S.R., Thompson-Torgerson C.S., Flavahan N.A. Estrogen increases smooth muscle expression of alpha2C-adrenoceptors and cold-induced constriction of cutaneous arteries. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1955-H1961.
54. Eid A.H., Chotani M.A., Mitra S., Miller T.J., Flavahan N.A. Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle alpha2C-adrenoceptors. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H266-H272.
55. Tantos A., Friedrich P., Tompa P. Cold stability of intrinsically disordered proteins. FEBS Lett. 2009, 583:465-469.